ARCS Inc.
Development of an Automated Assisted Reproductive Technology System
As of June, 2026
| City | Year of Establishment | Founder |
|---|---|---|
| Shibuya-ku, Tokyo | 2022 | Masayasu Tanase |
| Partner VC | Latest round of Fundraising | Valuation |
|---|---|---|
| HIRAC FUND（Money Forward Venture Partners,Inc.） | Series A | Non-Disclosure |
- Contact Information: 81-3-5801-6357
- info@arcs-inc.jp
- Website: ARCS Inc.
Program name
Deep-Tech Startups Support Program
Research theme
Development of an Automated Assisted Reproductive Technology System
Business Plan
Leveraging artificial intelligence (AI) and robotics technologies, the company aims to create a world where everyone has access to safe, high-quality fertility treatment. In particular, at assisted reproductive technology (ART) clinics, embryologists handle human sperm and eggs to perform fertilization and culture procedures.
These tasks face challenges including a shortage of embryologists and variability in clinical outcomes due to differences in operator skill level. The purpose of this project is to address these challenges through a work automation system that reduces the burden on medical professionals and improves treatment success rates (i.e., pregnancy rates).
Research Outline
The project will complete a prototype of the automation system and advance it toward practical implementation through performance verification and other evaluations. In parallel, R&D activities targeting global expansion will be initiated, and overseas business development activities will be pursued proactively.
| Phase | Business Area/Field | Research Period | Research Grant Amount |
|---|---|---|---|
| STS | Healthcare | 2026-2027FY | JPY 389 million |
International collaborative technology demonstration
| Countries/Regions | Collaborative activity outline |
|---|---|
| United States, Europe |
|
Last Updated : October 5, 2026